Back to All Events

Updates in Keratoconus Research: Present and Future

 
 

This course explores recent trends in keratoconus treatment, including the rising use of corneal collagen crosslinking (CXL), risk factors for treatment failure, and complications. Attendees will learn about sociodemographic influences, CXL outcomes, and patient management strategies.

Over 1300 attended our event and we received amazing feedback!

Feedback from anonymous survey:

  • Great lecturer! Presented material in an easily comprehended manner.

  • This is a fascinating overview of a number of aspects of treatment modalities, and the socioeconomic factors involved. Dr. Syed is welcome to return to this forum!

  • Fantastic speaker! Please bring her back!

  • Great research analysis and approach for the CE.

  • Dr. Syed is very knowledgable on the topic of Keratoconus. Very well spoken as well. I would enjoy more lectures from this doctor.

  • Great lecture and update on new treatment options for KCN.

  • Dr. Zeba was excellent. I could keep up taking notes. Well presented and was not rushed.

  • Did no know the speaker but I would definitely attend future lectures by Dr. Syed, she was excellent!!

  • Doctor was very concise and well spoken.

Speaker: Dr. Zeba Syed

Moderator: Dr. Ariel Cerenzie

COPE ID: 101462-TD

Category: Trt/Mngmnt Ocular Disease

This event is COPE approved for 1 hour of CE credit.

Handout
Previous
Previous
November 25

The Truth About Presbyopia Drops: Evidence-based Cases and Myth-busting Insights

Next
Next
December 17

Trial by Data: Efficacy and Safety Across Today’s Pharmacologic Presbyopia Drops